Pharmain Corporation, based in Bothell, is dedicated to developing in-home therapy solutions for liver disease and cancer. Their investigational drug therapy, PHIN-214, offers promising potential for patients, although it has not yet received approval from regulatory agencies worldwide.
With a focus on innovative treatments, Pharmain Corporation strives to improve the quality of life for individuals battling serious illnesses. As a partner in healthcare, they are committed to advancing medical research and providing hope for those in need.
Generated from their website's infomation